United States - English - NLM (National Library of Medicine)

physicians total care, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 25 mg - imitrex tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. imitrex tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications). safety and effectiveness of imitrex tablets have not been established for cluster headache, which is present in an older, predominantly male population. imitrex tablets should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular , or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive imitrex tablets. ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort, vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovascular syndromes include, but are not limited to, strokes of any ty

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 6 mg in 0.5 ml - imitrex injection is indicated for 1) the acute treatment of migraine attacks with or without aura and 2) the acute treatment of cluster headache episodes. imitrex injection is not for use in the management of hemiplegic or basilar migraine (see contraindications). imitrex injection should not be given intravenously because of its potential to cause coronary vasospasm. imitrex injection should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive imitrex injection. ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort, vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovascular syndromes include, but are not limited to, strokes of any type as well as transient ischemic attacks. peripheral v

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kallangur hardware pty ltd - chlorine present as sodium hypochlorite - pool chlorine - spa | swimming pool | outdoor spa | spa pools - algae | bacteria

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - eletriptan hydrobromide (unii: m41w832ta3) (eletriptan - unii:22qoo9b8ki) - eletriptan 20 mg - eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with eletriptan hydrobromide, reconsider the diagnosis of migraine before eletriptan hydrobromideis administered to treat any subsequent attacks. - eletriptan hydrobromidetablets arenot intended for the prevention of migraine attacks. - safety and effectiveness of eletriptan hydrobromidehave not been established for cluster headache. eletriptan hydrobromide is contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal's angina [see warnings and precautions (5.1)]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorde

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - abamectin; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - abamectin anthelmintic active 18.0 g/l; n-methyl-2-pyrrolidone solvent other 265.0 g/l; liquid hydrocarbon solvent other 58.0 g/l - miticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell international pty ltd - permethrin - emulsifiable concentrate - permethrin pyrethroid active 100.0 g/kg - insecticide

United States - English - NLM (National Library of Medicine)

macleods pharmaceuticals limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 2.5 mg - zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan are administered to treat any subsequent attacks. - zolmitriptan is not indicated for the prevention of migraine attacks.  - safety and effectiveness of zolmitriptan have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see warnings and precautions (

United States - English - NLM (National Library of Medicine)

beta kimya sanayi ve ticaret anonim sirketi - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - for hand washing to decrease bacteria on the skin

United States - English - NLM (National Library of Medicine)

beta kimya sanayi ve ticaret anonim sirketi - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for hand washing to decrease bacteria on the skin

United States - English - NLM (National Library of Medicine)

directrx - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 25 mg - sumatriptan tablets, usp are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: use only if a clear diagnosis of migraine headache has been established. if a patient has no response to the first migraine attack treated with sumatriptan tablets, usp, reconsider the diagnosis of migraine before sumatriptan tablets, usp are administered to treat any subsequent attacks. sumatriptan tablets, usp are not indicated for the prevention of migraine attacks. safety and effectiveness of sumatriptan tablets, usp have not been established for cluster headache. sumatriptan tablets are contraindicated in patients with: ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal’s angina [see warnings and precautions (5.1)] wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see warn